AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7394
+0.0144 (1.99%)
Sep 9, 2025, 12:36 PM - Market open

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $8.61 million. The enterprise value is $16.44 million.

Market Cap8.61M
Enterprise Value 16.44M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

AEON Biopharma has 11.64 million shares outstanding. The number of shares has decreased by -94.62% in one year.

Current Share Class 11.64M
Shares Outstanding 11.64M
Shares Change (YoY) -94.62%
Shares Change (QoQ) +177.80%
Owned by Insiders (%) 29.18%
Owned by Institutions (%) 16.73%
Float 8.20M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.12

Current Ratio 1.12
Quick Ratio 0.92
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -129.01%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -708.80%
Revenue Per Employee n/a
Profits Per Employee -$327,200
Employee Count5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.66% in the last 52 weeks. The beta is 0.71, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y) 0.71
52-Week Price Change -98.66%
50-Day Moving Average 0.77
200-Day Moving Average 8.92
Relative Strength Index (RSI) 48.56
Average Volume (20 Days) 81,383

Short Selling Information

The latest short interest is 253,955, so 2.18% of the outstanding shares have been sold short.

Short Interest 253,955
Short Previous Month 361,308
Short % of Shares Out 2.18%
Short % of Float 3.10%
Short Ratio (days to cover) 2.26

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -17.95M
Pretax Income n/a
Net Income -1.64M
EBITDA -17.87M
EBIT -17.95M
Earnings Per Share (EPS) -$0.40
Full Income Statement

Balance Sheet

The company has $8.44 million in cash and $16.44 million in debt, giving a net cash position of -$8.00 million or -$0.69 per share.

Cash & Cash Equivalents 8.44M
Total Debt 16.44M
Net Cash -8.00M
Net Cash Per Share -$0.69
Equity (Book Value) -15.85M
Book Value Per Share -1.37
Working Capital 1.13M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.58 million and capital expenditures -$4,000, giving a free cash flow of -$13.58 million.

Operating Cash Flow -13.58M
Capital Expenditures -4,000
Free Cash Flow -13.58M
FCF Per Share -$1.17
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 94.62%
Shareholder Yield 94.62%
Earnings Yield -19.38%
FCF Yield -160.87%

Analyst Forecast

The average price target for AEON Biopharma is $360.00, which is 48,588.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $360.00
Price Target Difference 48,588.13%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:72.

Last Split Date Feb 26, 2025
Split Type Reverse
Split Ratio 1:72

Scores

Altman Z-Score n/a
Piotroski F-Score 1